Dr. Albert Liu, Director, HIV Prevention Studies
Albert Liu, MD, MPH is the Director of HIV Prevention Intervention Studies at Bridge HIV and an Assistant Clinical Professor of Medicine at the University of California, San Francisco (UCSF). He is a board certified internist and instructs internal medicine residents in the care of underserved populations. Dr. Liu’s research focuses on the evaluation of pre-exposure prophylaxis (PrEP) as a novel HIV prevention strategy, strategies to promote PrEP adherence and the accurate measurement of drug exposure, and combination HIV prevention strategies. He has directed local trial efforts of the CDC-sponsored safety study of tenofovir in men who have sex with men (MSM) and is leading a cross-site analysis of sexual behavior and risk compensation in this cohort. He is also the San Francisco Department of Public Health co-principal investigator of the Global iPrEx trial and Open Label Extension and oversees overall protocol safety for the 11 trial sites as the iPrEx Medical Officer. He is currently leading an analysis of depression and how it correlates with sexual risk and PrEP adherence in iPrEx. Dr. Liu has also pioneered work in developing hair as a biomarker of drug exposure in PrEP studies. After completing his MD at the UCSF and MPH at the University of California, Berkeley, he served as Medical Director of the Haight Ashbury Free Medical Clinic for two years.